Condition
Axillary Lymph Node Metastasis
Total Trials
4
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Active Not Recruiting1
Completed1
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07596472Not Yet Recruiting
Ultrasound Monitoring of Clipped Lymph Nodes to Predict Axillary Response After Chemotherapy in Breast Cancer
NCT07428720Not ApplicableActive Not Recruiting
Axillary Lymph Node Changes After Neoadjuvant Therapy In Breast Cancer
NCT07418411Not ApplicableCompleted
Additional Imaging Methods for Assessing Axillary Lymph Node Involvement in Breast Cancer
NCT05768451Unknown
Ultrasound Radiomics for Predicting Breast Cancer and Axillary Lymph Node Metastasis
Showing all 4 trials